Pages that link to "Q72426993"
Jump to navigation
Jump to search
The following pages link to Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) (Q72426993):
Displaying 50 items.
- European evidence based consensus on the diagnosis and management of Crohn's disease: special situations (Q22242050) (← links)
- Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease (Q24234938) (← links)
- Aminosalicylates for induction of remission or response in Crohn's disease (Q24235730) (← links)
- Interventions for prevention of post-operative recurrence of Crohn's disease (Q24240542) (← links)
- Aminosalicylates for induction of remission or response in Crohn's disease (Q26471183) (← links)
- New steroids and new salicylates in inflammatory bowel disease: a critical appraisal (Q28192793) (← links)
- Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease (Q28390019) (← links)
- Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease (Q33588549) (← links)
- Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? (Q33617826) (← links)
- Medical therapy for inflammatory bowel disease (Q33662010) (← links)
- Clinical pharmacokinetics of slow release mesalazine (Q34025193) (← links)
- Mesalamine for prophylaxis of small bowel Crohn's disease recurrence (Q34027828) (← links)
- Prevention of postoperative recurrence in Crohn's disease (Q34027907) (← links)
- Medical therapy for Crohn's disease: the state of the art. (Q34161820) (← links)
- Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence (Q34429640) (← links)
- Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. (Q34575542) (← links)
- Medical treatment of Crohn's disease (Q34745601) (← links)
- Inflammatory bowel disease. Medical therapy of specific clinical presentations (Q34745614) (← links)
- Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis (Q34758714) (← links)
- Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field (Q34789021) (← links)
- Assessing disease activity and disease activity indices for inflammatory bowel disease (Q35003823) (← links)
- Recent developments in inflammatory bowel disease (Q35037876) (← links)
- Risk of postoperative recurrence and postoperative management of Crohn's disease (Q35171537) (← links)
- Postoperative outcome of Crohn's disease in 30 children (Q35353256) (← links)
- Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease (Q35364265) (← links)
- Factors affecting recurrence after surgery for Crohn's disease. (Q35851097) (← links)
- Postoperative management of ulcerative colitis and Crohn's disease (Q36325184) (← links)
- European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis (Q36397893) (← links)
- Current therapy of inflammatory bowel disease in children (Q36622124) (← links)
- Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients (Q37146097) (← links)
- The pharmacoeconomics of biologic therapy for IBD. (Q37687871) (← links)
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis (Q37814539) (← links)
- Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn’s disease (Q37892884) (← links)
- Postoperative recurrent luminal Crohnʼs Disease: A systematic review (Q37914790) (← links)
- Preventing postoperative recurrence in Crohn's disease: what does the future hold? (Q38153302) (← links)
- Analysis of risk factors - especially different types of plexitis - for postoperative relapse in Crohn's disease (Q38616623) (← links)
- A Practical Approach to Preventing Postoperative Recurrence in Crohn's Disease (Q38810125) (← links)
- Strategies for Preventing Endoscopic Recurrence of Crohn's Disease 1 Year after Surgery: A Network Meta-Analysis (Q39384575) (← links)
- Newer treatments for inflammatory bowel disease (Q41185508) (← links)
- Inflammatory bowel disease in the elderly. Practical treatment guidelines (Q41435344) (← links)
- Protagonist: Crohn's disease recurrence can be prevented after ileal resection (Q41773696) (← links)
- Clinical and endoscopic recurrence after surgical resection in patients with Crohn's disease (Q41851680) (← links)
- Antagonist: Crohn's disease recurrence can be prevented after ileal resection (Q41890935) (← links)
- Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease (Q41891210) (← links)
- Risk Stratification for Prevention of Recurrence of Postoperative Crohn's Disease (Q47147978) (← links)
- Advances in the management of Crohn's disease: economic and clinical potential of infliximab (Q50636148) (← links)
- Drug treatments for maintaining remission in Crohn's disease. A lifetime cost-utility analysis (Q50642540) (← links)
- Medical therapy of inflammatory bowel disease (Q72824188) (← links)
- Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI (Q73386821) (← links)
- Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there? (Q73386844) (← links)